Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 4, 2016, Pages 1074-1079

  Lou, Nanhong ^a   Takano, Takahiro ^a   Pei, Yong ^a   Xavier, Anna L ^a   Goldman, Steven A ^a,b   Nedergaard, Maiken ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Blood brain barrier; Clopidogrel; Microglia; Purinergic receptors; Stroke

Indexed keywords

CLOPIDOGREL; PURINERGIC P2Y12 RECEPTOR; ANTITHROMBOCYTIC AGENT; P2RY12 PROTEIN, MOUSE; TICLOPIDINE;

ANIMAL EXPERIMENT; ARTICLE; BLEEDING TIME; BLOOD BRAIN BARRIER; BRAIN PROTECTION; CELL ACTIVATION; CELL MOTILITY; CEREBROVASCULAR DISEASE; CHEMOTAXIS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CELL MOTION; DRUG EFFECTS; PHYSIOLOGY;

ANIMALS; BLOOD-BRAIN BARRIER; CELL MOVEMENT; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; PLATELET AGGREGATION INHIBITORS; RECEPTORS, PURINERGIC P2Y12; TICLOPIDINE;

EID: 84955563702     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1520398113     Document Type: Article

References (55)

1. Aguzzi A, Barres BA, Bennett ML (2013) Microglia: Scapegoat, saboteur, or something else? Science 339(6116): 156-161.
2. Marín-Teva JL, et al. (2004) Microglia promote the death of developing Purkinje cells. Neuron 41(4): 535-547.
3. Paolicelli RC, et al. (2011) Synaptic pruning by microglia is necessary for normal brain development. Science 333(6048): 1456-1458.
4. Schafer DP, et al. (2012) Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74(4): 691-705.
5. Tremblay ME, Lowery RL, Majewska AK (2010) Microglial interactions with synapses are modulated by visual experience. PLoS Biol 8(11): E1000527.
6. Ueno M, et al. (2013) Layer V cortical neurons require microglial support for survival during postnatal development. Nat Neurosci 16(5): 543-551.
7. Miron VE, et al. (2013) M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci 16(9): 1211-1218.
8. Kingwell K (2012) Neurodegenerative disease: Microglia in early disease stages. Nat Rev Neurol 8(9): 475.
9. Perry VH, Nicoll JA, Holmes C (2010) Microglia in neurodegenerative disease. Nat Rev Neurol 6(4): 193-201.
10. Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci 22(9): 391-397.
11. Lo EH, Dalkara T, Moskowitz MA (2003) Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4(5): 399-415.
12. Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE (2005) Does drug abuse alter microglial phenotype and cell turnover in the context of advancing HIV infection? Neuropathol Appl Neurobiol 31(3): 325-338.
13. Roth TL, et al. (2014) Transcranial amelioration of inflammation and cell death after brain injury. Nature 505(7482): 223-228.
14. Hollopeter G, et al. (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409(6817): 202-207.
15. Sasaki Y, et al. (2003) Selective expression of Gi/o-coupled ATP receptor P2Y12 in microglia in rat brain. Glia 44(3): 242-250.
16. Catalin B, Cupido A, Iancau M, Albu CV, Kirchhoff F (2013) Microglia: First responders in the central nervous system. Rom J Morphol Embryol 54(3): 467-472.
17. Davalos D, et al. (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8(6): 752-758.
18. Haynes SE, et al. (2006) The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 9(12): 1512-1519.
19. Ransohoff RM, Cardona AE (2010) The myeloid cells of the central nervous system parenchyma. Nature 468(7321): 253-262.
20. Foster CJ, et al. (2001) Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest 107(12): 1591-1598.
21. Raju NC, Eikelboom JW, Hirsh J (2008) Platelet ADP-receptor antagonists for cardiovascular disease: Past, present and future. Nat Clin Pract Cardiovasc Med 5(12): 766-780.
22. Savi P, et al. (2001) P2y(12), a new platelet ADP receptor, target of clopidogrel. Biochem Biophys Res Commun 283(2): 379-383.
23. Diener HC, et al.; Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group (2008) Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: A double-blind, active and placebo-controlled study. Lancet Neurol 7(10): 875-884.
24. Pereillo JM, et al. (2002) Structure and stereochemistry of the active metabolite of clopidogrel. Drug Metab Dispos 30(11): 1288-1295.
25. Wilhite DB, et al. (2003) Managing PAD with multiple platelet inhibitors: The effect of combination therapy on bleeding time. J Vasc Surg 38(4): 710-713.
26. Boneu B, Destelle G (1996) Platelet anti-aggregating activity and tolerance of clopidogrel in atherosclerotic patients. Thromb Haemost 76(6): 939-943.
27. Andre P, et al. (2003) P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. J Clin Invest 112(3): 398-406.
28. Dorsam RT, Kunapuli SP (2004) Central role of the P2Y12 receptor in platelet activation. J Clin Invest 113(3): 340-345.
29. Watanabe W, Matsunaga S, Higashi T, Fukui K, Itoh K (2008) In vivo manipulation of fluorescently labeled organelles in living cells by multiphoton excitation. J Biomed Opt 13(3): 031213.
30. Chung SH, Clark DA, Gabel CV, Mazur E, Samuel AD (2006) The role of the AFD neuron in C. elegans thermotaxis analyzed using femtosecond laser ablation. BMC Neurosci 7: 30.
31. Fu Y, et al. (2014) A cortical circuit for gain control by behavioral state. Cell 156(6): 1139-1152.
32. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139(2): 271-279.
33. Daneman R, Zhou L, Kebede AA, Barres BA (2010) Pericytes are required for bloodbrain barrier integrity during embryogenesis. Nature 468(7323): 562-566.
34. Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57(2): 178-201.
35. Simon J, et al. (2002) Characterization and channel coupling of the P2Y(12) nucleotide receptor of brain capillary endothelial cells. J Biol Chem 277(35): 31390-31400.
36. Wihlborg AK, et al. (2004) ADP receptor P2Y12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels. Arterioscler Thromb Vasc Biol 24(10): 1810-1815.
37. Krzeminski P, Misiewicz I, Pomorski P, Kasprzycka-Guttman T, Baranska J (2007) Mitochondrial localization of P2Y1, P2Y2 and P2Y12 receptors in rat astrocytes and glioma C6 cells. Brain Res Bull 71(6): 587-592.
38. Zhang Y, et al. (2014) An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci 34(36): 11929-11947.
39. Marteau F, et al. (2003) Pharmacological characterization of the human P2Y13 receptor. Mol Pharmacol 64(1): 104-112.
40. Savi P, et al. (2006) The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts. Proc Natl Acad Sci USA 103(29): 11069-11074.
41. Yusuf S, et al.; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345(7): 494-502.
42. Steinhubl SR, et al.; CREDO Investigators. Clopidogrel for the Reduction of Events During Observation (2002) Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. JAMA 288(19): 2411-2420.
43. Connolly SJ, et al.; ACTIVE Investigators (2009) Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med 360(20): 2066-2078.
44. Hankey GJ, et al.; CHARISMA Trial Investigators (2010) Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: A prespecified substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) trial. Stroke 41(8): 1679-1683.
45. Bhatt DL, et al.; CHARISMA Investigators (2006) Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354(16): 1706-1717.
46. Bhatt DL, et al.; CHARISMA Investigators (2007) Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol 49(19): 1982-1988.
47. del Zoppo GJ, et al. (2007) Microglial activation and matrix protease generation during focal cerebral ischemia. Stroke 38(2, Suppl): 646-651.
48. Lo EH, Pan Y, Matsumoto K, Kowall NW (1994) Blood-brain barrier disruption in experimental focal ischemia: Comparison between in vivo MRI and immunocytochemistry. Magn Reson Imaging 12(3): 403-411.
49. Webster CM, et al. (2013) Microglial P2Y12 deficiency/inhibition protects against brain ischemia. PLoS One 8(8): E70927.
50. Gelosa P, et al. (2014) Microglia is a key player in the reduction of stroke damage promoted by the new antithrombotic agent ticagrelor. J Cereb Blood Flow Metab 34(6): 979-988.
51. Taubert D, et al. (2004) Pharmacokinetics of clopidogrel after administration of a high loading dose. Thromb Haemost 92(2): 311-316.
52. Takano T, et al. (2006) Astrocyte-mediated control of cerebral blood flow. Nat Neurosci 9(2): 260-267.
53. Nishimura N, et al. (2006) Targeted insult to subsurface cortical blood vessels using ultrashort laser pulses: Three models of stroke. Nat Methods 3(2): 99-108.
54. Bonnefoy A, et al. (2006) Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13. Blood 107(3): 955-964.
55. Pérez P, Alarcón M, Fuentes E, Palomo I (2014) Thrombus formation induced by laser in a mouse model. Exp Ther Med 8(1): 64-68.